Genetic Overlap Between Type 1 Diabetes and Other Autoimmune Diseases

Overview

Journal Semin Immunopathol

Publisher Springer

Specialties Allergy & Immunology
Pathology

Date 2021 Oct 1

PMID 34595540

Citations 4

Authors

Ana Marquez

Javier Martin

Affiliations

Soon will be listed here.

Abstract

Type 1 diabetes (T1D) is a chronic disease caused by the destruction of pancreatic β cells, which is driven by autoreactive T lymphocytes. It has been described that a high proportion of T1D patients develop other autoimmune diseases (AIDs), such as autoimmune thyroid disease, celiac disease, or vitiligo, which suggests the existence of common etiological factors among these disorders. In this regard, genetic studies have identified a high number of loci consistently associated with T1D that also represent established genetic risk factors for other AIDs. In addition, studies focused on identifying the shared genetic component in autoimmunity have described several common susceptibility loci with a potential role in T1D. Elucidation of this genetic overlap has been useful in identifying key molecular pathways with a pathogenic role in multiple disorders. In this review, we summarize recent advances in understanding the shared genetic component between T1D and other AIDs and discuss how the identification of common pathogenic mechanisms can help in the development of new therapeutic approaches as well as in improving the use of existing drugs.

Citing Articles

Causal link between type 1 diabetes mellitus and juvenile idiopathic arthritis in Europe.

Lv M, Liu P, Li J, Peng Y, Yu S, Wu R Pediatr Res. 2025; .

PMID: 40055534 DOI: 10.1038/s41390-025-03975-5.

Coeliac disease: complications and comorbidities.

Ludvigsson J, Yao J, Lebwohl B, Green P, Yuan S, Leffler D Nat Rev Gastroenterol Hepatol. 2025; .

PMID: 39875649 DOI: 10.1038/s41575-024-01032-w.

Pleiotropic Bias and Study Design Considerations in Genetic Association Studies.

Eybpoosh S, Ahmadi S Med J Islam Repub Iran. 2024; 38:51.

PMID: 39399603 PMC: 11469697. DOI: 10.47176/mjiri.38.51.

Bidirectional association between inflammatory bowel disease and type 1 diabetes: a nationwide matched cohort and case-control study.

Sun J, Yao J, Olen O, Halfvarsson J, Bergman D, Ebrahimi F Lancet Reg Health Eur. 2024; 46:101056.

PMID: 39286331 PMC: 11402305. DOI: 10.1016/j.lanepe.2024.101056.

Deciphering Autoimmune Diseases: Unveiling the Diagnostic, Therapeutic, and Prognostic Potential of Immune Repertoire Sequencing.

Hu Y, Huang J, Wang S, Sun X, Wang X, Yu H Inflammation. 2024; .

PMID: 38914737 DOI: 10.1007/s10753-024-02079-2.

References

Onkamo P, Vaananen S, Karvonen M, Tuomilehto J . Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends. Diabetologia. 2000; 42(12):1395-403. DOI: 10.1007/s001250051309. View

Bakay M, Pandey R, Grant S, Hakonarson H . The Genetic Contribution to Type 1 Diabetes. Curr Diab Rep. 2019; 19(11):116. DOI: 10.1007/s11892-019-1235-1. View

Clayton D . Prediction and interaction in complex disease genetics: experience in type 1 diabetes. PLoS Genet. 2009; 5(7):e1000540. PMC: 2703795. DOI: 10.1371/journal.pgen.1000540. View

Redondo M, Yu L, Hawa M, Mackenzie T, Pyke D, Eisenbarth G . Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia. 2001; 44(3):354-62. DOI: 10.1007/s001250051626. View

Kakleas K, Soldatou A, Karachaliou F, Karavanaki K . Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1DM). Autoimmun Rev. 2015; 14(9):781-97. DOI: 10.1016/j.autrev.2015.05.002. View

Husebye E, Anderson M . Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis. Immunity. 2010; 32(4):479-87. PMC: 2859971. DOI: 10.1016/j.immuni.2010.03.016. View

Huber A, Menconi F, Corathers S, Jacobson E, Tomer Y . Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev. 2008; 29(6):697-725. PMC: 2583387. DOI: 10.1210/er.2008-0015. View

Richard-Miceli C, Criswell L . Emerging patterns of genetic overlap across autoimmune disorders. Genome Med. 2012; 4(1):6. PMC: 3334554. DOI: 10.1186/gm305. View

Ounissi-Benkalha H, Polychronakos C . The molecular genetics of type 1 diabetes: new genes and emerging mechanisms. Trends Mol Med. 2008; 14(6):268-75. DOI: 10.1016/j.molmed.2008.04.002. View

10.

Erlich H, Valdes A, Noble J, Carlson J, Varney M, Concannon P . HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes. 2008; 57(4):1084-92. PMC: 4103420. DOI: 10.2337/db07-1331. View

11.

Morel P, Dorman J, Todd J, McDevitt H, Trucco M . Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. Proc Natl Acad Sci U S A. 1988; 85(21):8111-5. PMC: 282365. DOI: 10.1073/pnas.85.21.8111. View

12.

Lee K, Wucherpfennig K, Wiley D . Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol. 2001; 2(6):501-7. DOI: 10.1038/88694. View

13.

Hu X, Deutsch A, Lenz T, Onengut-Gumuscu S, Han B, Chen W . Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk. Nat Genet. 2015; 47(8):898-905. PMC: 4930791. DOI: 10.1038/ng.3353. View

14.

Lenz T, Deutsch A, Han B, Hu X, Okada Y, Eyre S . Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases. Nat Genet. 2015; 47(9):1085-90. PMC: 4552599. DOI: 10.1038/ng.3379. View

15.

Naito T, Suzuki K, Hirata J, Kamatani Y, Matsuda K, Toda T . A deep learning method for HLA imputation and trans-ethnic MHC fine-mapping of type 1 diabetes. Nat Commun. 2021; 12(1):1639. PMC: 7955122. DOI: 10.1038/s41467-021-21975-x. View

16.

Bourgey M, Calcagno G, Tinto N, Gennarelli D, Margaritte-Jeannin P, Greco L . HLA related genetic risk for coeliac disease. Gut. 2007; 56(8):1054-9. PMC: 1955501. DOI: 10.1136/gut.2006.108530. View

17.

Schweiger D, Mendez A, Kunilo Jamnik S, Bratanic N, Bratina N, Battelino T . High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease. Autoimmunity. 2016; 49(4):240-7. DOI: 10.3109/08916934.2016.1164144. View

18.

Jacobson E, Huber A, Tomer Y . The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun. 2008; 30(1-2):58-62. PMC: 2244911. DOI: 10.1016/j.jaut.2007.11.010. View

19.

Bell G, Horita S, KARAM J . A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes. 1984; 33(2):176-83. DOI: 10.2337/diab.33.2.176. View

20.

Nistico L, Buzzetti R, Pritchard L, Van der Auwera B, Giovannini C, Bosi E . The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet. 1996; 5(7):1075-80. DOI: 10.1093/hmg/5.7.1075. View